Mannitol and Dopamine in Patients Undergoing Cardiopulmonary Bypass: A Randomized Clinical Trial

Anesthesia and Analgesia

Volumn 97, Issue 5, 2003, Pages 1222-1229

  Carcoana, Olivia V ^a   Mathew, Joseph P ^b   Davis, Elizabeth ^a   Byrne, Daniel W ^c   Hayslett, John P ^a   Hines, Roberta L ^a   Garwood, Susan ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOCAPROIC ACID; ANTIFIBRINOLYTIC AGENT; APROTININ; BETA 2 MICROGLOBULIN; DOPAMINE; FUROSEMIDE; INOTROPIC AGENT; MANNITOL; MIDAZOLAM; PANCURONIUM; SUFENTANIL; VASODILATOR AGENT;

ADULT; AGED; ANESTHESIA INDUCTION; ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; FEMALE; HEMODYNAMICS; HOSPITALIZATION; HUMAN; INTENSIVE CARE; KIDNEY FUNCTION; KIDNEY TUBULE; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; URINE FLOW RATE;

EID: 0142150306     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ANE.0000086727.42573.A8     Document Type: Article

References (38)

1. Mora Mangano C, Diamondstone LS, Ramsay JG, et al. Renal dysfunction after myocardial revascularization: risk factors, adverse outcomes, and hospital resource utilization. Ann Intern Med 1998;128:194-203.
2. Hollenberg NK, Adams DF, Mendell P, et al. Renal vascular responses to dopamine: haemodynamic and angiographic observations in normal man. Clin Sci Mol Med 1973;45:733-42.
3. Mousdale S, Clyburn PA, Mackie AM, et al. Comparison of the effects of dopamine, dobutamine and dopexamine upon renal blood flow: a study in normal healthy volunteers. Br J Clin Pharmacol 1988;25:555-60.
4. Palsson J, Ricksten S-E, Houltz E, Lundin S. Effects of dopamine, dopexamine and dobutamine on renal excretory function during experimental sepsis in conscious rats. Acta Anaesthesiol Scand 1997;41:392-8.
5. Gomez-Garre DN, Lopez-Farre A, Eleno N, Lopez-Novoa JM. Comparative effects of dopexamine and dopamine on glycerol-induced acute renal failure in rats. Ren Fail 1996;18:59-68.
6. Davis RF, Lappas DG, Kirklin JK, et al. Acute oliguria after cardiopulmonary bypass: renal functional improvement with low-dose dopamine infusion. Crit Care Med 1982;10:852-6.
7. Hilberman M, Maseda J, Stinson EB, et al. The diuretic properties of dopamine in patients after open-heart operation. Anesthesiology 1984;61:489-94.
8. Costa P, Ottino GM, Matani A, et al. Low-dose dopamine during cardiopulmonary bypass in patients with renal dysfunction. J Cardiothorac Anesth 1990;4:469-73.
9. Slogoff S, Reul GJ, Keats AS, et al. Role of perfusion pressure and flow in major organ dysfunction after cardiopulmonary bypass. Ann Thorac Surg 1990;50:911-8.
10. Denton MD, Chertow GM, Brady HR. "Renal-dose" dopamine for the treatment of acute renal failure: scientific rationale, experimental studies and clinical trials. Kidney Int 1996;49:4-14.
11. Myles PS, Buckland MR, Schnek NJ, et al. Effect of "renal-dose" dopamine on renal function following cardiac surgery. Anaesth Intensive Care 1993;21:56-61.
12. Levey AS, Bosch JP, Breyer Lewis J, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction formula. Ann Intern Med 1999;130:461-70.
13. Westhuyzen J, McGiffin DC, McCarthy J, Fleming SJ. Tubular nephrotoxicity after cardiac surgery utilising cardiopulmonary bypass. Clin Chim Acta 1994;228:123-32.
14. Flynn FV. Assessment of renal function: selected developments. Clin Biochem 1990;23:49-54.
15. 2-microglobulin to diagnose tubulo-interstitial renal lesions in children. Kidney Int 1986;30:91-8.
16. Takemura T, Okada M, Hino S, et al. Course and outcome of tubulointerstitial nephritis and uveitis syndrome. Am J Kidney Dis 1999;34:1016-21.
17. Tanaka H, Waga S, Tateyama T, et al. Acute tubulointerstitial nephritis following intravenous immunoglobulin therapy in a male infant with minimal-change nephritic syndrome. Tohuku J Exp Med 1999;189:155-61.
18. Lopez-Menchero R, Miguel A, Garcia-Ramon R, et al. Importance of residual renal function in continuous ambulatory peritoneal dialysis: its influence on different patterns of renal replacement treatment. Nephron 1999;83:219-25.
19. Mustonen S, Ala-Houhala I, Tammela TL. Proteinuria and renal function during and after acute urinary retention. J Urol 1999;161:1781-4.
20. Taylor SA, Chivers ID, Price RG, et al. The assessment of biomarkers to detect nephrotoxicity using an integrated database. Environ Res 1997;75:23-33.
21. Turney JH. Acute renal failure: a dangerous condition. JAMA 1996;275:1516-7.
22. Carey RM, Siragy HM, Ragsdale NV, et al. Dopamine-1 and dopamine-2 mechanisms in the control of renal function. Am J Hypertens 1990;3:59S-63S.
23. Amenta F, Collier WL, Ricci A. Autoradiographic localization of vascular dopamine receptors. Am J Hypertens 1990;3:34S-36S.
24. Gaudio KM, Stromski M, Thulin G, et al. Postischemic hemodynamics and recovery of renal adenosine triphosphate. Am J Physiol 1986;251:F603-F609.
25. Mason J, Beck K, Dorge A, et al. Intracellular electrolyte composition of renal tubules following renal ischemia. Kidney Int 1981;20:61-70.
26. Tang AT, El-Gamel A, Keevil B, et al. The effect of 'renal-dose' dopamine on renal tubular function following cardiac surgery: assessed by measuring retinal binding protein. Eur J Cardiothorac Surg 1999;15:717-21.
27. Dehne MG, Boldt J, Heise D, et al. Tamm-Horsfall protein, alpha-1- and beta-2-microglobulin as kidney function markers in heart surgery. Anaesthesist 1995;44:545-51.
28. Fernandez F, de Miguel MD, Barrio V, Mallol J. Beta-2-microglobulin as an index of renal function after cardiopulmonary bypass surgery in children. Child Nephrol Urol 1988;9:326-30.
29. Paver-Erzen V, Pavlin K. Beta 2-microglobulin (B2M) as an indicator of impaired kidney function during and after cardiopulmonary bypass surgery (CPBS) in children. J Cardiothorac Vasc Anesth 1992;6:97.
30. 2-microglobulin. Clin Chim Acta 1983;129:27-37.
31. 2-microglobulin excretion by patients treated with aminoglycosides. Kidney Int 1980;17:654-61.
32. Sethi K, Diamond LH. Aminoglycoside nephrotoxicity and its predictability. Nephron 1981;27:265-70.
33. 2-microglobulin: the constant chain of HLA-antigens. Eur J Clin Invest 1980;10:293-300.
34. Hall PW III, Ricanati ES. Renal handling of beta-2-microglobulin in renal disorders: with special reference to hepatorenal syndrome. Nephron 1981;27:62-6.
35. 2-microglobulin in the dog. Kidney Int 1982;22:156-61.
36. Mogensen CE, Sølling K. Studies on renal tubular protein reabsorption: partial and near complete inhibition by certain amino acids. Scand J Clin Lab Invest 1977;37:477-86.
37. Bernard A, Amor AO, Viau C, Lauwerys R. The renal uptake of proteins: a nonselective process in conscious rats. Kidney Int 1988;34:175-85.
38. Jakobsen JA, Nossen JO, Jorgensen NP, Berg KJ. Renal tubular effects of diuretics and x-ray contrast media: a comparative study of equimolar doses in healthy volunteers. Invest Radiol 1993;28:319-24.